News
HC Wainwright & Co. Reiterates Buy on Pliant Therapeutics, Maintains $36 Price Target
7 Jun 24
News, Price Target, Reiteration, Analyst Ratings
Pliant Therapeutics To Present Data From Its Bexotegrast Program At The EASL International Liver Congress June 5-8, 2024
6 Jun 24
Biotech, News, General
Reported Earlier, Pliant Therapeutics Presented Bexotegrast Program Data At American Thoracic Society 2024 International Conference
22 May 24
News
HC Wainwright & Co. Reiterates Buy on Pliant Therapeutics, Maintains $36 Price Target
15 May 24
News, Price Target, Reiteration, Analyst Ratings
Pliant Therapeutics' Drug Trial Shows Promise In Reversing Lung Fibrosis In Patients
14 May 24
Biotech, News, Health Care, Trading Ideas, General
Citigroup Maintains Buy on Pliant Therapeutics, Lowers Price Target to $44
7 May 24
News, Price Target, Analyst Ratings
These Analysts Revise Their Forecasts On Pliant Therapeutics Following Q1 Earnings
7 May 24
Earnings, News, Price Target, Markets, Trading Ideas
RBC Capital Maintains Outperform on Pliant Therapeutics, Lowers Price Target to $45
7 May 24
News, Price Target, Analyst Ratings
Oppenheimer Reiterates Outperform on Pliant Therapeutics, Raises Price Target to $48
7 May 24
News, Price Target, Reiteration, Analyst Ratings
Oppenheimer Maintains Outperform on Pliant Therapeutics, Raises Price Target to $48
7 May 24
News, Price Target, Analyst Ratings
Needham Reiterates Buy on Pliant Therapeutics, Maintains $38 Price Target
7 May 24
News, Price Target, Reiteration, Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Pliant Therapeutics, Maintains $36 Price Target
7 May 24
News, Price Target, Reiteration, Analyst Ratings
Pliant Therapeutics Q1 EPS $(0.78) Misses $(0.77) Estimate
6 May 24
Earnings, Earnings Misses, News
Needham Reiterates Buy on Pliant Therapeutics, Maintains $38 Price Target
10 Apr 24
News, Price Target, Reiteration, Analyst Ratings
Press releases
Pliant Therapeutics Announces Appointment of Steve Krognes to Board of Directors
13 Jun 24
News, Management, Press Releases
Pliant Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
12 Jun 24
Press Releases
Pliant Therapeutics Presents Data from its Bexotegrast Program at the American Thoracic Society International Conference
21 May 24
News, Health Care, Press Releases, General
Pliant Therapeutics Announces Positive Topline Data from a Phase 2a Collagen PET Imaging Clinical Trial of Bexotegrast in Patients with Idiopathic Pulmonary Fibrosis
14 May 24
Press Releases
Pliant Therapeutics to Participate in Upcoming Investor Events
1 May 24
News, Press Releases